Atlas Trials

Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence

Clinical trial NCT01175941 · COMPLETED

Trial details

NCT number
NCT01175941
Sponsor
Norgine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fecal Incontinence
Start date
2010-08-01
Primary completion
2011-11-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.